Liver Enzyme Correlated with C-Reactive Protein as a Biomarker of Metabolic Syndrome in Elderly Patients: Metabolic Syndrome Related with Liver Enzyme and CRP

Rubina Ghani; Shaista  Emad; Samia  Perwaiz Khan; Uzma  Naseeb; Fahad  Ahmed; Sehrish  Zia

doi:10.54393/pjhs.v4i05.364

Authors

Rubina Ghani Department of Biochemistry, Jinnah Medical & Dental College/Sohail University, Karachi, Pakistan
Shaista Emad Department of Biochemistry, Jinnah Medical & Dental College/Sohail University, Karachi, Pakistan
Samia Perwaiz Khan Department of Pharmacology, Jinnah Medical & Dental College/ Sohail University, Karachi, Pakistan
Uzma Naseeb Deparment of Biochemistry, Jinnah Sindh Medical University, Karachi, Pakistan
Fahad Ahmed Department of Medical Technology, Indus College of Medical Technology & Allied Health, Indus Hospital, Karachi, Pakistan
Sehrish Zia Department of Biochemistry, Jinnah Medical & Dental College/Sohail University, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v4i05.364

Keywords:

Liver Enzymes, C-Reactive Protein, Metabolic Syndrome, Body Mass Index, Cardiovascular Disease

Abstract

Metabolic syndrome is a multifactorial disease with various risk factors that arise from insulin resistance associated with obesity, diabetes, hypertension, and dyslipidemias. Objective: To investigate the association between C-Reactive Protein and various risk factors related to CVS and metabolic health in elderly adults. Increased levels of various liver enzymes were found to be indicative of the progression of metabolic syndrome. Methods: In this study, total of 150 individuals with diagnosed metabolic syndrome were included, and they were compared to an equal number of control cases. The participants were selected from individuals visiting the Pathology and Molecular Biology Laboratories in Karachi for lab investigations. before collecting blood samples, basic vital signs, blood pressure, height, and waist circumference measurements were recorded to determine the participants' body mass index. The blood samples were then taken to assess liver enzyme levels and CRP. Results: The study examined and compared the levels of inflammatory marker and liver enzymes in both cases of metabolic syndrome (MetS) and the control group. The findings revealed a significant association (p-value of 0.001) between metabolic syndrome and elevated levels of liver enzymes and CRP. Specifically, the suspected cases of metabolic syndrome showed strong correlations with alanine aminotransferase, gamma-glutamyl transferase, and aspartate aminotransferase. However, alkaline phosphatase did not show substantial differences between the two groups. Conclusions: Our research revealed correlation between metabolic syndrome, liver enzymes and CRP. These findings indicate that high levels of liver enzymes and CRP can be indicative of cardiovascular functional abnormalities in elderly patients with metabolic syndrome.

References

Lu J, Wang L, Li M, Xu Y, Jiang Y, Wang W, et al. Metabolic syndrome among adults in China: the 2010 China noncommunicable disease surveillance. The Journal of Clinical Endocrinology & Metabolism. 2017 Feb; 102(2): 507-15. doi: 10.1210/jc.2016-2477. DOI: https://doi.org/10.1210/jc.2016-2477

Wang S, Zhang J, Zhu L, Song L, Meng Z, Jia Q, et al. Association between liver function and metabolic syndrome in Chinese men and women. Scientific Reports. 2017 Mar; 7(1): 44844. doi: 10.1038/srep44844. DOI: https://doi.org/10.1038/srep44844

Engin A. The definition and prevalence of obesity and metabolic syndrome. Obesity and Lipotoxicity. 2017 Jun; 960: 1-7. doi: 10.1007/978-3-319-48382-5_1. DOI: https://doi.org/10.1007/978-3-319-48382-5_1

Ali N, Sumon AH, Fariha KA, Asaduzzaman M, Kathak RR, Molla NH, et al. Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population. Scientific Reports. 2021 Mar; 11(1): 6640. doi: 10.1038/s41598-021-86216-z. DOI: https://doi.org/10.1038/s41598-021-86216-z

Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. The Journal of Clinical Investigation. 2013 Jul; 123(7): 2764-72. doi: 10.1172/JCI67227. DOI: https://doi.org/10.1172/JCI67227

Saklayen MG. The global epidemic of the metabolic syndrome. Current Hypertension Reports. 2018 Feb; 20(2): 1-8. doi:10.1007/s11906-018-0812-z. DOI: https://doi.org/10.1007/s11906-018-0812-z

Ko SH, Baeg MK, Han KD, Ko SH, Ahn YB. Increased liver markers are associated with higher risk of type 2 diabetes. World Journal of Gastroenterology: WJG. 2015 Jun; 21(24): 7478. doi: 10.3748/wjg. v21.i24.7478. DOI: https://doi.org/10.3748/wjg.v21.i24.7478

Ghani R, Hingorjo MR, Khan SP, Naseeb U, Emad S, Khattak AK, et al. Role of C-reactive protein and gamma-glutamyl transferase in the diagnosis of metabolic syndrome. International Journal of Medicine and Medical Sciences. 2021 Dec; 9(4): 118-24. doi: 10.30918/IRJMMS.94.021.039.

Hsieh MH, Ho CK, Hou NJ, Hsieh MY, Lin WY, Yang JF, et al. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C. International Journal of Obesity. 2009 Nov; 33(11): 1309-17. doi: 10.1038/ijo.2009.172. DOI: https://doi.org/10.1038/ijo.2009.172

Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003 Nov; 26(11): 3153-9. doi: 10.2337/diacare.26.11.3153. DOI: https://doi.org/10.2337/diacare.26.11.3153

Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World Journal of Gastroenterology: WJG. 2008 Jan; 14(2): 185. doi: 10.3748/wjg.14.185. DOI: https://doi.org/10.3748/wjg.14.185

Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics. 2011 Aug; 34(3): 274-85. doi: 10.1111/j.1365-2036.2011. 04724.x. DOI: https://doi.org/10.1111/j.1365-2036.2011.04724.x

Valle-Martos R, Valle M, Martos R, Cañete R, Jiménez-Reina L, Cañete MD. Liver enzymes correlate with metabolic syndrome, inflammation, and endothelial dysfunction in prepubertal children with obesity. Frontiers in Pediatrics. 2021 Feb; 9: 629346. doi: 10.3389/fped.2021.629346. DOI: https://doi.org/10.3389/fped.2021.629346

Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gamma-glutamyltransferase and diabetes—a 4 year follow-up study. Diabetologia. 2003 Mar; 46: 359-64. doi 10.1007/s00125-003-1036-5. DOI: https://doi.org/10.1007/s00125-003-1036-5

Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. InSeminars in Liver Disease. 2001 Dec; 21(1): 017-26. doi: 10.1055/s-2001-12926. DOI: https://doi.org/10.1055/s-2001-12926

Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino Jr RB, Kempf J, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2004 Oct; 53(10): 2623-32. doi: 10.2337/diabetes.53.10.2623. DOI: https://doi.org/10.2337/diabetes.53.10.2623

Liangpunsakul S and Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III). The American Journal of the Medical Sciences. 2005 Mar; 329(3): 111-6. doi: 10.1097/00000441-200503000-00001. DOI: https://doi.org/10.1097/00000441-200503000-00001

Sattar N, Scherbakova O, Ford I, O’Reilly DS, Stanley A, Forrest E, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes. 2004 Nov; 53(11): 2855-60. doi: 10.2337/diabetes.53.11.2855. DOI: https://doi.org/10.2337/diabetes.53.11.2855

Christiana UI, Obiefuna AI, Egbuagha EU, Oshodi TA. Liver enzymes and markers of inflammation in Nigerian adults with metabolic syndrome. Journal of Clinical Sciences. 2015 Jan; 12(1): 24. doi: 10.4103/1595-9587.160764. DOI: https://doi.org/10.4103/1595-9587.160764

Chen S, Guo X, Yu S, Zhou Y, Li Z, Sun Y. Metabolic syndrome and serum liver enzymes in the general Chinese population. International Journal of Environmental Research and Public Health. 2016 Feb; 13(2): 223. doi: 10.3390/ijerph13020223. DOI: https://doi.org/10.3390/ijerph13020223